HEALWELL's DARWEN(TM) AI Platform Showcases a Pioneering Use of AI to Produce Regulatory-Grade Real-World Data (RWD) to Enhance Patient Access and Propel the Pharmaceutical Sector
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 21 2025
0mins
Source: Yahoo Finance
AI-Generated Real-World Data Presentation: HEALWELL, in partnership with Takeda Pharmaceutical, showcased AI-generated regulatory-grade real-world data on vedolizumab dose escalation for ulcerative colitis and Crohn's disease at the UEG Week in Berlin, demonstrating improved remission outcomes with more frequent dosing.
Unique AI Capabilities and Recognition: HEALWELL's DARWEN™ AI platform is recognized for its unique ability to generate real-world data and evidence, positioning the company as a leader in healthcare AI, and it has been named a finalist in Newsweek's AI Impact Awards 2025 for its contributions to clinical and commercial advancements.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
